World's Best Scientists 2026 revealed!

D-Index & Metrics

Social Sciences and Humanities

D-Index
69
Citations
41432
World Ranking
790
National Ranking
148

Overview

Michael Parker is affiliated with the University of Oxford in the United Kingdom. Their research spans multiple disciplines, primarily focusing on Medicine and Biochemistry, Genetics, and Molecular Biology. The scientist's work contributes significantly to various subfields, including Molecular Biology, Immunology, Oncology, Infectious Diseases, and Ecology.

Their most recent published papers include:

  • Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia (2022, Cell Metabolism)
  • Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers (2021, Science Translational Medicine)
  • Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms (2020, Nature Metabolism)
  • An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability (2021, Nature Communications)
  • C-reactive protein, immunothrombosis and venous thromboembolism (2022, Frontiers in Immunology)

Frequent collaborators in their research include:

  • Craig J. Morton
  • Tracy L. Nero
  • Michelle P. Christie
  • Angel F. López
  • Karen S. Cheung Tung Shing

The scientist publishes regularly in several academic venues. The most frequent publication outlets are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Acta Crystallographica Section A Foundations and Advances
  • Nature Communications
  • eLife
  • Journal of Biological Chemistry

Their research topics cover areas including:

  • Ubiquitin and proteasome pathways
  • Immune Cell Function and Interaction
  • Cytokine Signaling Pathways and Interactions
  • Neuroblastoma Research and Treatments
  • Streptococcal Infections and Treatments
  • T-cell and B-cell Immunology
  • Protein Degradation and Inhibitors

Best Publications

  • A global reference for human genetic variation.

    Adam Auton;Gonçalo R. Abecasis;David M. Altshuler;Richard M. Durbin

  • Fair Allocation of Scarce Medical Resources in the Time of Covid-19.

    Ezekiel J. Emanuel;Govind Persad;Ross Upshur;Beatriz Thome

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • A global reference for human genetic variation

    Adam Auton;Gonçalo R. Abecasis;David M. Altshuler;Richard M. Durbin

  • Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data

    Caroline F Wright;Tomas W Fitzgerald;Wendy D Jones;Stephen Clayton

  • Rowe and Kahn's Model of Successful Aging Revisited: Positive Spirituality--The Forgotten Factor.

    Martha R. Crowther;Michael W. Parker;W. A. Achenbaum;Walter L. Larimore

  • Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

    Carmel Toomes;Helen M. Bottomley;Richard M. Jackson;Katherine V. Towns

  • Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders

    Caroline F Wright;Caroline F Wright;Jeremy F McRae;Stephen Clayton;Giuseppe Gallone

  • Mutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on wnt signaling

    Lot Snijders Blok;Erik Madsen;Jane Juusola;Christian Gilissen

  • Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders

    Víctor Faundes;Víctor Faundes;William G. Newman;Laura Bernardini;Natalie Canham

  • Good and Bad Research Collaborations: Researchers' Views on Science and Ethics in Global Health Research.

    Michael Parker;Patricia Kingori

  • Ethics of instantaneous contact tracing using mobile phone apps in the control of the COVID-19 pandemic.

    Michael J Parker;Christophe Fraser;Lucie Abeler-Dörner;David Bonsall

  • Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.

    Anna Middleton;Katherine I Morley;Katherine I Morley;Eugene Bragin;Helen V Firth

  • Deciding for imperilled newborns: medical authority or parental autonomy?

    Hazel E McHaffie;Ian A Laing;Michael Parker;John McMillan

  • How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum

    Siddharth Banka;Ratna Veeramachaneni;William Reardon;Emma Howard

  • Religiosity and mental health in southern, community-dwelling older adults.

    Michael Parker;L. Lee Roff;D. L. Klemmack;H. G. Koenig

  • A qualitative study of health system barriers to accessibility and utilization of maternal and newborn healthcare services in Ghana after user-fee abolition

    John Kuumuori Ganle;Michael Parker;Raymond Fitzpatrick;Easmon Otupiri

  • Ethical issues in human genomics research in developing countries.

    Jantina de Vries;Jantina de Vries;Susan J Bull;Susan J Bull;Ogobara Doumbo;Muntaser Ibrahim

  • Should clinicians incorporate positive spirituality into their practices? What does the evidence say?

    Walter L. Larimore;Michael Parker;Martha Crowther

  • Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.

    Michael P. Mackley;Benjamin Fletcher;Michael Parker;Hugh Watkins

  • Genetic information: a joint account?

    Michael Parker;Anneke M Lucassen

Frequent Co-Authors

Matthew E. Hurles
Matthew E. Hurles Wellcome Sanger Institute
Dominic P. Kwiatkowski
Dominic P. Kwiatkowski University of Oxford
Helen V. Firth
Helen V. Firth University of Cambridge
Sassy Molyneux
Sassy Molyneux University of Oxford
David R. FitzPatrick
David R. FitzPatrick University of Edinburgh
Harold G. Koenig
Harold G. Koenig Duke University
Jill Clayton-Smith
Jill Clayton-Smith University of Manchester
Tony Hope
Tony Hope University of Oxford
Evan E. Eichler
Evan E. Eichler University of Washington
Nicholas P. J. Day
Nicholas P. J. Day University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Opportunities abound for students interested in Social Sciences and Humanities, especially through online degree programs that offer flexibility and accessibility. When researching a program, the psychology degree cost is an important consideration, with affordable online options making this pathway more attainable for many.

If your goal is a career in social work, seeking out the online master's in social work programs that are both reputable and easier to access can help you get started quickly and efficiently. Similarly, those interested in clinical psychology may consider doctoral programs such as the psyd program, which are available online and may offer specialized training for licensure.

For students eager to complete their education in a shorter span, accelerated online mft programs allow you to enter the workforce faster as a marriage and family therapist. Each of these online pathways can lead to diverse roles in counseling, therapy, research, education, and beyond—opening multiple career doors within the Social Sciences and Humanities fields.

Best Scientists Citing Michael Parker

Trending Scientists